SCHEMBL8662533

SCHEMBL8662533

CCOC(=O)Cc1ccc(C#Cc2ccc3c(c2)C(CC)(CC)CCO3)nn1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.41
RARA P10276 1/20 0.41
RARB P10826 1/20 0.41
RARG P13631 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.31
CLK1 P49759 1/20 0.31
CYP26A1 O43174 1/20 0.31
NR3C1 P04150 1/20 0.30
CSF1R P07333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657991 0.89 CYP3A4 (0.38) CYP3A4RARARARBRARGKMT2A
SCHEMBL7651191 0.89 RARA (0.35) CYP3A4RARARARBRARGKMT2A
SCHEMBL8659868 0.87 CYP3A4 (0.32) CYP3A4RARARARBRARGKMT2A
SCHEMBL8661287 0.86 SMN1; SMN2 (0.33) CYP3A4RARARARBRARGKMT2A
SCHEMBL8659621 0.86 CYP3A4 (0.42) CYP3A4RARARARBRARGKMT2A
SCHEMBL8661009 0.85 CYP3A4 (0.46) CYP3A4RARARARBRARGKMT2A
SCHEMBL8846374 0.84 FDFT1 (0.42) CYP3A4RARARARBRARGKMT2A
SCHEMBL8662240 0.83 CYP3A4 (0.54) CYP3A4RARARARBRARGKMT2A
SCHEMBL8659605 0.82 RARA (0.41) CYP3A4RARARARBRARGKMT2A
SCHEMBL8663075 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750693-A THIOCHROMANYL OR CHROMANYL COMPOUNDS AS ANTICARCINOGINIC AGENTS, SKIN DISORDERS AND ATHEROSCLEROSIS ALLERGAN (US) 1998-05-12 US disclosed
US-5677451-A CONTROLLING CELL DIFFERENTIATION; SKIN DISORDERS; ANTICANCER AGENTS ALLERGAN (US) 1997-10-14 US disclosed